Details for New Drug Application (NDA): 212541
✉ Email this page to a colleague
NDA 212541 describes PYRAZINAMIDE, which is a drug marketed by Hikma, Macleods Pharms Ltd, and Novitium Pharma, and is included in three NDAs. It is available from eight suppliers. Additional details are available on the PYRAZINAMIDE profile page.
The generic ingredient in PYRAZINAMIDE is pyrazinamide. There are seven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the pyrazinamide profile page.
The generic ingredient in PYRAZINAMIDE is pyrazinamide. There are seven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the pyrazinamide profile page.
Summary for 212541
| Tradename: | PYRAZINAMIDE |
| Applicant: | Macleods Pharms Ltd |
| Ingredient: | pyrazinamide |
| Patents: | 0 |
Suppliers and Packaging for NDA: 212541
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PYRAZINAMIDE | pyrazinamide | TABLET;ORAL | 212541 | ANDA | Macleods Pharmaceuticals Limited | 33342-447 | 33342-447-03 | 10 TABLET in 1 BOTTLE (33342-447-03) |
| PYRAZINAMIDE | pyrazinamide | TABLET;ORAL | 212541 | ANDA | Macleods Pharmaceuticals Limited | 33342-447 | 33342-447-07 | 30 TABLET in 1 BOTTLE (33342-447-07) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
| Approval Date: | Jul 27, 2020 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
